Clinical Trials
Search Results 1 - 10 of 288 recordsCan Telaprevir reduce treatment duration, side-effects and cost?
(Science News, 02 Sep 2010 )Hedwig Kresse, healthcare analyst at Datamonitor, provides expert comment following Vertex Pharmaceuticals announcing results from the phase three Illuminate study: "The Illuminate study results confirm ....
Phase three trial to evaluate ARQ 197
(Science News, 26 Aug 2010 )ArQule and Daiichi Sankyo announce that they will move forward with a phase three clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small ....
Carfilzomib could be new treatment for relapsed myeloma patients
(Science News, 25 Aug 2010 )The International Myeloma Foundation (IMF) says promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies. ....
Head and neck cancer clinical trial reports high complete pathological response rate
(Science News, 17 Aug 2010 )BioVex announces that the data from its completed phase one/two clinical study of OncoVexGM-CSF for the first line treatment of head and neck cancer is being published in Clinical Cancer Research. The ....
Rivaroxaban shows risk reduction of DVT
(Science News, 16 Aug 2010 )Bayer announces that a novel, convenient single-drug treatment approach with oral rivaroxaban met the primary efficacy endpoint of non-inferiority in the Einstein-DVT phase three clinical trial. It showed ....
Advaxis to conduct cervical cancer trial in India
(Top News, 16 Aug 2010 )Advaxis receives formal permission from the Drugs Controller General India (DCGI) to conduct a phase two clinical trial of ADXS11-001, the company's flagship drug construct, among 110 women with advanced, ....
Study identifies potential biomarkers of Velcade in relapsed MCL patients
(Science News, 13 Aug 2010 )Millennium: The Takeda Oncology Company reports new correlative science data from the Pinnacle trial of Velcade (bortezomib) in patients with relapsed/refractory mantle cell lymphoma (MCL). The data, ....
Contrave trial shows patients more likely to lose weight
(Science News, 12 Aug 2010 )Orexigen announces that results from its COR-I trial of Contrave were published online in the journal Lancet. COR-I was the largest of the four, 56-week, phase three trials supporting the new drug application ....
First human clinical trial of embryonic stem cell-based therapy
(Science News, 12 Aug 2010 )Geron announces that the US FDA has notified the company that the clinical hold placed on its investigational new drug (IND) application has been lifted and the phase one clinical trial of GRNOPC1 in ....
Phase three trial to evaluate pimavanserin
(Science News, 10 Aug 2010 )Acadia announces that it has initiated a new phase three trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis ....
